DCGO
DocGo Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.40
−0.52%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 294.7M | 322.2M | 616.6M | 624.3M | 440.5M |
| Cost of Revenue | 205.9M | 223.4M | 403.0M | 428.9M | 285.8M |
| Gross Profit | 88.8M | 98.8M | 213.6M | 195.4M | 154.7M |
| Operating Expenses | |||||
| R&D Expense | 14.1M | 13.6M | 11.6M | 10.9M | 5.4M |
| SG&A Expense | 151.7M | 158.7M | 157.4M | 153.0M | 116.9M |
| General & Admin Expense | 150.2M | 157.3M | 155.9M | 150.2M | 112.2M |
| Selling & Marketing Expense | 1.5M | 1.4M | 1.5M | 2.8M | 4.8M |
| Other Expenses | 34.0M | 15.7M | 15.9M | 16.4M | 10.6M |
| Total Operating Expenses | 199.8M | 187.9M | 184.9M | 180.3M | 132.9M |
| Cost and Expenses | 405.8M | 411.4M | 587.9M | 609.2M | 418.7M |
| Operating Income (EBIT) | (111.1M) | (89.2M) | 28.7M | 15.1M | 21.8M |
| Non-Operating | |||||
| Interest Income | — | — | 237.0K | 1.7M | 762.7K |
| Interest Expense | 341.5K | 1.0M | 2.2M | — | — |
| Net Interest Income | (341.5K) | (1.0M) | (1.9M) | 1.7M | 762.7K |
| Other Non-Op Income/Expense | (78.3M) | (98.3M) | (939.7K) | 1.2M | 950.3K |
| Non-Operating Income (excl Interest) | 60.3M | 97.3M | (989.5K) | (1.2M) | (950.3K) |
| EBT (Pre-Tax Income) | (189.4M) | (187.5M) | 27.7M | 16.3M | 22.8M |
| Income Tax Expense | 17.3M | 8.9M | 14.4M | 6.2M | (8.0M) |
| Bottom Line | |||||
| Net Income | (192.4M) | (182.4M) | 20.0M | 6.9M | 34.6M |
| Earnings from Cont. Ops | (206.7M) | (196.4M) | 13.4M | 10.0M | 30.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (192.4M) | (182.4M) | 20.0M | 6.9M | 34.6M |
| Per Share | |||||
| Basic EPS | ($1.96) | ($1.84) | $0.20 | $0.07 | $0.34 |
| Diluted EPS | ($1.96) | ($1.84) | $0.18 | $0.06 | $0.34 |
| Revenue Per Share | $2.98 | $3.25 | $6.02 | $6.03 | $4.35 |
| Shares | |||||
| Basic Shares Outstanding | 98.8M | 99.1M | 102.4M | 103.5M | 101.2M |
| Diluted Shares Outstanding | 98.8M | 99.1M | 109.4M | 105.6M | 103.0M |
| Profitability Metrics | |||||
| EBITDA | (158.1M) | (170.8M) | 45.6M | 32.7M | 33.3M |
| D&A | 13.3M | 15.7M | 15.9M | 16.4M | 10.6M |
| EBIT | (171.3M) | (186.5M) | 29.7M | 16.3M | 22.8M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026